Literature DB >> 29635139

Bilateral absence of the cruciate ligaments with meniscal dysplasia: Unexpected diagnosis in a child with juvenile idiopathic arthritis.

Andrew J Degnan1, Daniel A Kietz2, Jan S Grudziak3, Amisha Shah4.   

Abstract

Bilateral agenesis of the cruciate ligaments is a rare congenital anomaly. We report a unique case of a young girl who had congenital short femur and diagnosed with polyarticular juvenile idiopathic arthritis (JIA) and later discovered to have congenital absence of both anterior and posterior cruciate ligaments and meniscal dysplasia in both the knees when MRI was performed at 11 years of age. The MRI was performed to evaluate knee laxity and persistent symptoms despite medical management and multiple steroid injections for arthritis treatment. This patient is one of the youngest with congenital absence of both the cruciate ligaments to be treated with ACL reconstruction. We highlight the unique radiographic imaging manifestations of congenital cruciate ligament agenesis and emphasize the role of MRI to confirm and depict additional intraarticular abnormalities.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Congenital; Cruciate ligament agenesis; Juvenile idiopathic arthritis; Meniscal dysplasia

Mesh:

Year:  2018        PMID: 29635139     DOI: 10.1016/j.clinimag.2018.03.015

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  2 in total

Review 1.  Management of Anterior Cruciate Ligament Aplasia for the Arthroscopy Surgeons: A Systematic Review.

Authors:  Srinivas B S Kambhampati; Karthik Vishwanathan; Nagashree Vasudeva; Bobby Anand; Anirudh P S Kambhampati; Dipen K Menon
Journal:  Indian J Orthop       Date:  2022-05-24       Impact factor: 1.033

2.  How should congenital absence of cruciate ligaments be treated? A case report and literature review.

Authors:  Ran Lu; Dong-Ping Zhu; Neng Chen; He Sun; Ze-Hui Li; Xue-Wei Cao
Journal:  World J Clin Cases       Date:  2019-10-06       Impact factor: 1.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.